Abstract
Background
Objective
Materials and Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe toReferences
- Deep brain stimulation: current challenges and future directions.Nat Rev Neurol. 2019; 15: 148-160
- Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.Lancet Neurol. 2020; 19: 491-501
- Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.Arch Neurol. 2011; 68: 165
- Targeting of the subthalamic nucleus for deep brain stimulation: a survey among Parkinson disease specialists.World Neurosurg. 2017; 99: 41-46
- Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.Brain Stimul. 2021; 14: 1109-1117
- Stimulation sweet spot in subthalamic deep brain stimulation - myth or reality? A critical review of literature.Stereotact Funct Neurosurg. 2021; 99: 425-442
- Patient-specific analysis of the volume of tissue activated during deep brain stimulation.Neuroimage. 2007; 34: 661-670
- Image-based biophysical modeling predicts cortical potentials evoked with subthalamic deep brain stimulation.Brain Stimul. 2021; 14: 549-563
- Probabilistic analysis of activation volumes generated during deep brain stimulation.Neuroimage. 2011; 54: 2096-2104
- Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition.J Neurophysiol. 2004; 91: 1457-1469
- Patient-specific models of deep brain stimulation: influence of field model complexity on neural activation predictions.Brain Stimul. 2010; 3: 65-67
- Lead-DBS v2: towards a comprehensive pipeline for deep brain stimulation imaging.Neuroimage. 2019; 184: 293-316
- Holographic reconstruction of axonal pathways in the human brain.Neuron. 2019; 104: 1056-1064.e3
- Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor.Brain. 2014; 137: 109-121
- Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease.Neuroimage. 2017; 158: 332-345
- StimVision v2: examples and applications in subthalamic deep brain stimulation for Parkinson's disease.Neuromodulation. 2021; 24: 248-258
- Opportunities of connectomic neuromodulation.Neuroimage. 2020; 221117180
- Quantifying axonal responses in patient-specific models of subthalamic deep brain stimulation.Neuroimage. 2018; 172: 263-277
- Automatic localization of the subthalamic nucleus on patient-specific clinical MRI by incorporating 7 T MRI and machine learning: application in deep brain stimulation.Hum Brain Mapp. 2019; 40: 679-698
- Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease.Ann Neurol. 2019; 86: 527-538
- A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei.Sci Data. 2018; 5180063
- Comparison of methodologies for modeling directional deep brain stimulation electrodes.PLoS One. 2021; 16e0260162
- A driving-force predictor for estimating pathway activation in patient-specific models of deep brain stimulation.Neuromodulation. 2019; 22: 403-415
- Computational analysis of subthalamic nucleus and lenticular fasciculus activation during therapeutic deep brain stimulation.J Neurophysiol. 2006; 96: 1569-1580
- Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus.J Neurol Neurosurg Psychiatry. 2008; 79: 813-819
- Electrophysiological characterization of the hyperdirect pathway and its functional relevance for subthalamic deep brain stimulation.Exp Neurol. 2022; 352114031
- Frequency-specific optogenetic deep brain stimulation of subthalamic nucleus improves parkinsonian motor behaviors.J Neurosci. 2020; 40: 4323-4334
- Short pulse width widens the therapeutic window of subthalamic neurostimulation.Ann Clin Transl Neurol. 2015; 2: 427-432
- Therapeutic window of deep brain stimulation using cathodic monopolar, bipolar, semi-bipolar, and anodic stimulation.Neuromodulation. 2019; 22: 451-455
- Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects.Parkinsonism Relat Disord. 2018; 55: 61-67
- Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration.Neuroimage. 2009; 46: 786-802
- Registration accuracy of CT/MRI fusion for localisation of deep brain stimulation electrode position: an imaging study and systematic review.Stereotact Funct Neurosurg. 2016; 94: 159-163
- Factors influencing electrode position and bending of the proximal lead in deep brain stimulation for movement disorders.Stereotact Funct Neurosurg. 2020; 98: 300-312
- Accuracy of different three-dimensional subcortical human brain atlases for DBS -lead localisation.NeuroImage Clin. 2018; 20: 868-874
- Role of soft-tissue heterogeneity in computational models of deep brain stimulation.Brain Stimul. 2017; 10: 46-50
- A statistical framework for quantification and visualisation of positional uncertainty in deep brain stimulation electrodes.Comput Methods Biomech Biomed Eng Imaging Vis. 2019; 7: 438-449
Comments
Article info
Publication history
Publication stage
In Press Corrected ProofFootnotes
Source(s) of financial support: This work was supported by grants from the National Institutes of Health (R01 NS105690; F31 NS098696).
Conflict of Interest: Cameron C. McIntyre is a paid consultant for Boston Scientific Neuromodulation, receives royalties from Hologram Consultants, Neuros Medical, and Qr8 Health, and is a shareholder in the following companies: Hologram Consultants, Surgical Information Sciences, BrainDynamics, CereGate, Autonomic Technologies, Cardionomic, and Enspire DBS. Angela M. Noecker is a paid consultant for Hologram Consultants. Kelsey L. Bower is an employee for CereGate and completed an internship with Boston Scientific. Anneke M. Frankemolle-Gilbert reported no conflict of interest.